Eric Schmidt the company and act as an adviser to co-founders Page and Brin. Google gave him a $100 million equity award in 2011 when he stepped down as CEO. On 4 April 2011, Page replaced Schmidt as the CEO. On December 21, 2017, Schmidt announced he would be stepping down as the executive chairman of Alphabet. While working at Google, Schmidt was involved in activities that later became the subject of the High-Tech Employee Antitrust Litigation case that resulted in a settlement of $415 million paid by Adobe, Apple, Google and Intel to employees. In one incident, after receiving a complaint
MannKind Corporation in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin). Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman. In November 2015, Hakan Edstrom stepped down as CEO and president and will remain until July, 2017 to provide other services for the company. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In May 2017, Michael Castagna was named CEO of MannKind Corporation. MannKind's corporate headquarters are in Westlake